SCHEMBL4246720

SCHEMBL4246720

COC(=O)/C=C(\Oc1cccc([N+](=O)[O-])c1)C(=O)OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
MAPT P10636 5/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
MAPK1 P28482 2/20 0.50
HSP90AA1 P07900 1/20 0.50
HPGD P15428 1/20 0.50
CACNA1B Q00975 1/20 0.50
APBA1 Q02410 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
NLRP1 Q9C000 1/20 0.50
F2 P00734 1/20 0.49
HGFAC Q04756 1/20 0.47
HTT P42858 2/20 0.44
TRPV1 Q8NER1 1/20 0.44
LMNA P02545 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ALOX5 P09917 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4246726 1.00 ALDH1A1 (0.50) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL4256581 1.00 ALDH1A1 (0.50) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL4251631 0.83 GAA (0.51) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL4251629 0.83 GAA (0.51) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL4254429 0.83 GAA (0.51) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL4256029 0.81 GLO1 (0.53) ALDH1A1MAPTMEN1KMT2AHSP90AA1
SCHEMBL4251542 0.81 MAPT (0.46) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL4253509 0.81 GLO1 (0.53) ALDH1A1MAPTMEN1KMT2AHSP90AA1
SCHEMBL4253504 0.81 GLO1 (0.53) ALDH1A1MAPTMEN1KMT2AHSP90AA1
SCHEMBL4251537 0.81 MAPT (0.46) ALDH1A1MAPTMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2105431-A1 Process for Producing Chromone Compound Sumitomo Chemical Company, Limited (JP) 2009-09-30 EP disclosed
EP-2105432-A1 Process for Producing Chromone Compound Sumitomo Chemical Company, Limited (JP) 2009-09-30 EP disclosed
EP-1867626-A2 Process for producing chromone compound Sumitomo Chemical Company, Limited (JP) 2007-12-19 EP disclosed
US-20060217565-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-09-28 US disclosed
US-7094914-B2 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-08-22 US disclosed
US-20050085664-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LMITED (JP) 2005-04-21 US disclosed
EP-1479667-A1 PROCESS FOR PRODUCING CHROMONE COMPOUND Sumitomo Chemical Company, Limited (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050085664-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL ALDH1A1 3157/4885MAPT 4765/4885MEN1 1358/4885
US-20060217565-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL ALDH1A1 3157/4885MAPT 4765/4885MEN1 1358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.